Provided by Tiger Fintech (Singapore) Pte. Ltd.

RxSIGHT, INC.

8.65
-0.6270-6.76%
Volume:670.07K
Turnover:5.93M
Market Cap:354.05M
PE:-10.83
High:9.28
Open:9.28
Low:8.63
Close:9.28
52wk High:58.23
52wk Low:6.32
Shares:40.92M
Float Shares:32.44M
Volume Ratio:0.57
T/O Rate:2.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7992
EPS(LYR):-0.7064
ROE:-11.66%
ROA:-8.65%
PB:1.27
PE(LYR):-12.25

Loading ...

Investors File Class Action Lawsuit Against RxSight Inc. Over Alleged Securities Fraud

Reuters
·
Aug 22

RxSight Inc. Faces Securities Fraud Allegations as Investors File Class Action Lawsuit

Reuters
·
Aug 16

RxSight Inc. to Participate in Upcoming Wells Fargo Healthcare Conference

Reuters
·
Aug 15

RxSight Is Maintained at Neutral by UBS

Dow Jones
·
Aug 09

J.P. Morgan Remains a Sell on RxSight (RXST)

TIPRANKS
·
Aug 09

UBS Adjusts RxSight Price Target to $8 From $16, Maintains Neutral Rating

MT Newswires Live
·
Aug 08

Rxsight Inc : Stifel Cuts Target Price to $8 From $9

THOMSON REUTERS
·
Aug 08

Piper Sandler Sticks to Their Hold Rating for RxSight (RXST)

TIPRANKS
·
Aug 08

RxSight (RXST) Gets a Hold from BTIG

TIPRANKS
·
Aug 08

U.S. RESEARCH ROUNDUP-Bd, Caci International, Caterpillar

Reuters
·
Aug 08

Rxsight Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

RxSight (RXST) Q2 Loss Beats Estimates

Motley Fool
·
Aug 08

Ophthalmic medical tech firm RxSight Q2 revenue falls

Reuters
·
Aug 08

Rxsight Q2 Operating Expenses USD 39.2 Million

Reuters
·
Aug 08

Rxsight Inc - Reiterates 2025 Full-Year REV Guidance

THOMSON REUTERS
·
Aug 08

Rxsight, Inc. Appoints Raymond W. Cohen To Its Board Of Directors

Reuters
·
Aug 04

RxSight appoints Raymond Cohen to its board of directors

TIPRANKS
·
Aug 04

RxSight Inc. Appoints Raymond W. Cohen to Board of Directors to Propel Growth in Vision Technology

Reuters
·
Aug 04

Rxsight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

THOMSON REUTERS
·
Aug 04

RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025

GlobeNewswire
·
Jul 25